WORLAND STEPHEN T 4
4 · eFFECTOR Therapeutics, Inc. · Filed May 17, 2024
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Award
Common Stock
2024-05-15$1.68/sh+1,806$3,039→ 12,494 total
Holdings
- 22,493(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.